Illumina Jumps Most in 15 Months on First-Quarter Profit
This article is for subscribers only.
Illumina Inc. rose the most in almost 15 months after the maker of genetic decoders reported earnings that exceeded analysts’ estimates on higher sales.
Illumina climbed 13 percent to $62.44 at the close in New York, its biggest intraday gain since Jan. 25, 2012. The San Diego-based company reported first-quarter earnings excluding one-time items of 46 cents a share, beating the 38 cent average of 21 estimates compiled by Bloomberg.